EIC Scaling Club Growth Forum 2026
We are thrilled to be attending the Growth Forum on 18 March – a day of big ideas, bold conversations, and brilliant people. Let’s connect
Welcome to the team, Andrea Sadlonova!
We are pleased to announce that Andrea Sadlonova is joining our team as Head of clinical and regulatory affairs as of January 2026. Andrea
Another great milestone for Glycanostics!
Another great milestone for Glycanostics! We are pleased to announce that European patent has been granted in respect of the Standard for glycoprofiling of proteins
Prestigious award!
Great news for Glycanostics! It is a great pleasure to announce that our leading scientist Jan Tkac, PhD. received a prestigious award “Rad Ľudovíta Štúra
Medica 2025
This year we are exhibiting at Medica 2025 congress in Duesseldorf for the first time. Please meet us in our booth No. 15C41 in pavillion
Welcome to the team, Ivan Durovcik!
It is our great pleasure to announce that Ivan Durovcik decided to join Glycanostics team as Chief Operating Officer in October 2025. Ivan brings more
Glycanostics selected for the EIC Scaling Club
We are proud to announce that we have been selected as one of the 120 most promising deep tech companies in the European Union to
We received a grant from the Recovery and Resilience Plan
We are pleased to announce that we have received a grant from the Recovery and Resilience plan of 3 million EUR. It is intended for
Innovate Slovakia
We are very pleased that Innovate Slovakia has included us to the list of the most promising and innovative startups to watch in 2024. Success
Run for healthy breasts
On Saturday May 25th our team of runners joined forces at the event “Run for Healthy Breasts“, aimed to support the fight against breast cancer
Interview for daily newspaper SME
Read the interview we gave to the daily newspaper SME on the topic of early diagnosis of cancer. We are very grateful for all the
Become a part of our success!
Our vision is to create a world where cancer is diagnosed early and treated successfully. We are pleased to announce that we have launched a
